You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 6, June 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (83)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Glucagonoma Syndrome

Report of Two Cases and Literature Review

Alan N. Binnick, MD; Steven K. Spencer, MD; W. Landon Dennison, Jr, MD; Edward S. Horton, MD

Arch Dermatol. 1977;113(6):749-754.


Abstract

• The glucagonoma syndrome is characterized by dermatitis, stomatitis, elevated serum glucagon levels, abnormal glucose tolerance, weight loss, and anemia—all in association with a glucagonsecreting alpha-cell tumor of the pancreas. A review of 21 cases showed strikingly similar features. A generalized, symmetrical dermatitis initially appeared to be asteatotic or eczematous over the perineum, buttocks, and lower extremities. Gradually, a more characteristic migratory necrolytic erythema with transient bulla formation and erosions developed in intertriginous and dependent areas. Histologically, the most specific features included necrolysis of the upper epidermis, with liquefaction necrosis of the granular cell layer and subcorneal clefting or blister formation. The dermatologist is often first to examine such patients; early recognition of this syndrome with prompt surgical removal of the primary pancreatic lesion may afford cure of the neoplasm.

(Arch Dermatol 113:749-754, 1977)



Author Affiliations

From the Section of Dermatology (Drs Binnick and Spencer), Hitchcock Clinic and the Department of Medicine (Drs Binnick and Spencer), Dartmouth Medical School, Hanover, NH, and the Department of Medicine (Drs Horton and Dennison), University of Vermont College of Medicine, Burlington.


Footnotes

Accepted for publication Nov 19, 1976.

Reprint requests to Section of Dermatology, Hitchcock Clinic, Hanover, NH 03755 (Dr Spencer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Case Report of Superficial Necrolytic Dermatitis in a Beagle Dog with Diabetes Mellitus
Yoshida et al.
Toxicol Pathol 1996;24:498-501.
ABSTRACT  

Figurate and Bullous Eruption in Association With Breast Carcinoma
Watsky et al.
Arch Dermatol 1990;126:649-652.
ABSTRACT  

Commentary: Migratory Necrolytic Erythema
Braverman
Arch Dermatol 1982;118:796-798.
ABSTRACT  

Malignant Glucagonoma Syndrome: Response to Chemotherapy
MARYNICK et al.
ANN INTERN MED 1980;93:453-454.
ABSTRACT  

Necrolytic Migratory Erythema Without Glucagonoma: Report of Two Cases
Goodenberger et al.
Arch Dermatol 1979;115:1429-1432.
ABSTRACT  

Dermatology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers
DERMATOLOGY COMMITTEE
ANN INTERN MED 1979;91:804-805.
ABSTRACT  

Amino Acid Deficiency and the Skin Rash Associated with Glucagonoma
NORTON et al.
ANN INTERN MED 1979;91:213-215.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.